Indian Pharma Companies Set to Launch Generic Diabetes Medicines At 90% Lower Price
With the expiration of Boehringer Ingelheim’s patent on Empagliflozin, several Indian pharmaceutical companies are set to ...
NewsBytes3d
Suffering from diabetes? Your medicines are set to become cheaper
While Metformin continues to be the standard first-line treatment for Type-2 diabetes, newer therapies such as SGLT2 ...
Taiwan News18h
Vietnam Insulin Patch Pumps Market to Reach $14.68 Million by 2030, Growing at 9.56% CAGR
The Vietnam Insulin Patch Pumps Market was valued at USD 8.47 Million in 2024 and is projected to reach USD 14.68 Million by 2030, exhibiting a CAGR of 9.56% during the forecast period. The market is ...
EurekAlert!2d
VA merit grant to Wayne State University searches for new insights into onset of diabetes
A grant from the U.S. Department of Veterans Affairs (VA) will aid Wayne State University researchers in finding new insights into diabetes and its onset.
Medscape7d
1-Hour OGTT Best Postpartum Predictor of Future Diabetes
A new study found that a 1-hour post partum OGTT is more effective than the 2-hour test at predicting dysglycemia in women with or without a history of gestational diabetes.